Close Menu

"What does it take for a new technology to catch on in the labs?" Derek Lowe asks at In the Pipeline. First, he says that it has to actually be useful; secondly, it shouldn't be "useful but annoying." For that latter category, Lowe says that automation is often the driving factor, and that signs of failure include lack of automation or poorly designed automation.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.